2001-02 Harkness FellowLecturer in international health policy and Director of the master of science in international health policy programDepartment of Social Policy and AdministrationLondon School of Economics and Political Science

Harkness Project Title: Uptake and Utilization of Statins in the United States: Evidence from Medical Expenditure Panel Survey

Mentor: Steve Soumerai, Sc.D.

Placement: Harvard Medical School/Harvard Pilgrim Health Care

Biography at time of Harkness Fellowship: Panos Kanavos, a 2001–02 Commonwealth Fund Harkness Fellow in Health Care Policy, is a lecturer in international health policy and director of the master of science in international health policy program in the Department of Social Policy and Administration at the London School of Economics and Political Science. His research interests include the financing of health services, pharmaceutical policy, the economics of health-related high technology (pharmaceuticals, biotechnology, and medical devices), and the health problems of economies in transition. He has published widely on health care reform issues, pharmaceutical economics, and policy. Kanavos served as advisor on health care reform and pharmaceutical policy in a variety of Eastern European countries and the Philippines and is a former alternate member of the executive committee of the National Drug Organization of Greece. He has also served as temporary advisor to and has received research grants from the World Health Organization, World Bank, Organization for Economic Cooperation and Development, European Commission, and European Parliament.

Project: Panos Kanavos explored the predictors of statin use in the U.S. between 1996 and 1998 for both primary and secondary prevention. He also explored how statin use during this period compared with published evidence on good clinical practice. He used data from the Medical Expenditure Panel Survey (MEPS) to identify patients who, on the basis of published clinical evidence, would qualify to receive a statin. He also conducted a retrospective multivariate logistic analysis on predictors of statin use, including socioeconomic and clinical factors.

Career Activity Since Fellowship

Program Director of the Medical Technology Research Group at LSE Health, 2009

Reader in International Health Policy, Department of Social Policy, London School of Economics, 2006

Merck Fellow in Pharmaceutical Policy, LSE Health, 2006

Research Fellow in Pharmaceutical Economics, LSE Health and Social Care, London School of Economics and Political Science, 2003

Current Position: Director, International Health Policy Programme (Health Economics), LSE Health, and Senior Lecturer and Head, Medical Technology Research Unit, Department of Social Policy, London School of Economics. (1/2014)

Pollack M, Kanavos P, Link C. Variations in Prescribing Patterns of Atypical Antipsychotics: A Probit Analysis of the NAMCS and NHAMCS Surveys for the Period 1992 – 1999. Department of Economics, University of Delaware, May 2002.

Get Updates That Matter

Sign up to receive e-alerts and newsletters on the health policy topics you care about most.

Mission

The mission of The Commonwealth Fund is to promote a high-performing health care system that achieves better access, improved quality, and greater efficiency, particularly for society's most vulnerable, including low-income people, the uninsured, minority Americans, young children, and elderly adults.